Description

9H-Imidazo[4,5-F]Quinazoline(8Ci) is a high-purity, fused heterocyclic organic compound that serves as a critical advanced intermediate in pharmaceutical research and development. Its unique imidazoquinazoline scaffold is of significant interest for the synthesis of novel bioactive molecules, particularly in oncology and antiviral therapeutic areas. This compound is essential for medicinal chemists and R&D laboratories engaged in the discovery of new drug candidates targeting kinase inhibition and other key biological pathways.

Application

• Pharmaceutical Intermediate: A key building block for the synthesis of novel small-molecule drug candidates, especially kinase inhibitors.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies to optimize potency and selectivity of lead compounds.
• Oncology Drug Discovery: Core scaffold for developing potential therapeutics targeting various cancer-related enzymes and receptors.
• Antiviral Agent Development: Investigated as a precursor for compounds with potential activity against viral pathogens.
• Biochemical Tool Compound: Serves as a reference standard or probe in biochemical and pharmacological assays.
• Academic & Contract Research: Utilized in university and CRO settings for fundamental heterocyclic chemistry and drug discovery projects.

Basic Information

Product Name	9H-Imidazo[4,5-F]Quinazoline(8Ci)
CAS No.	25886-04-8
Molecular Formula	C9H6N4
Molecular Weight	170.17 g/mol
Synonyms	9H-Imidazo[4,5-f]quinazoline; Imidazo[4,5-f]quinazoline; 8CI-Quinazoline, 9H-imidazo[4,5-f]-; Quinazoline, imidazo[4,5-f]- (8CI); NSC 339586; 25886-04-8; Imidazo(4,5-f)quinazoline
EINECS	Contact for details

Quality Control

We supply 9H-Imidazo[4,5-F]Quinazoline(8Ci) in high-purity grades suitable for research and development. Our products undergo rigorous quality testing to ensure compliance with industry standards. Certificates of Analysis (COA) detailing purity, identity, and impurity profiles are available upon request. We adhere to cGMP principles for the manufacture of advanced pharmaceutical intermediates to ensure batch-to-batch consistency and traceability.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider storing under an inert atmosphere to maintain optimal purity.

Specification

Item	Specification
Appearance	Off-white to light yellow powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 95%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.